[1]
L. Głuszkiewicz, “BEYOND SYMPTOM CONTROL: ADHD PHARMACOTHERAPY AND REAL-WORLD RISK REDUCTION – A NARRATIVE REVIEW”, IJITSS, vol. 5, no. 3(51), Sep. 2026, doi: 10.31435/ijitss.3(51).2026.6564.